nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—Phototoxicity—Dapsone—malaria	0.0504	0.0696	CcSEcCtD
Adapalene—Pain of skin—Clindamycin—malaria	0.0397	0.0548	CcSEcCtD
Adapalene—Sunburn—Clindamycin—malaria	0.031	0.0427	CcSEcCtD
Adapalene—Instillation site pain—Clindamycin—malaria	0.0287	0.0396	CcSEcCtD
Adapalene—Application site pain—Dapsone—malaria	0.022	0.0303	CcSEcCtD
Adapalene—Skin irritation—Clindamycin—malaria	0.0216	0.0298	CcSEcCtD
Adapalene—Application site pain—Clindamycin—malaria	0.0213	0.0293	CcSEcCtD
Adapalene—RXRA—kidney—malaria	0.0205	0.0961	CbGeAlD
Adapalene—RARG—hematopoietic system—malaria	0.0184	0.0859	CbGeAlD
Adapalene—Burning sensation—Sulfadiazine—malaria	0.0181	0.0249	CcSEcCtD
Adapalene—RARA—hematopoietic system—malaria	0.0173	0.0807	CbGeAlD
Adapalene—Vesiculobullous rash—Clindamycin—malaria	0.0167	0.023	CcSEcCtD
Adapalene—Optic neuritis—Quinidine—malaria	0.0149	0.0206	CcSEcCtD
Adapalene—Optic neuritis—Quinine—malaria	0.0149	0.0206	CcSEcCtD
Adapalene—RARA—kidney—malaria	0.0142	0.0662	CbGeAlD
Adapalene—Skin discolouration—Sulfadiazine—malaria	0.0139	0.0192	CcSEcCtD
Adapalene—Redness—Clindamycin—malaria	0.0138	0.0191	CcSEcCtD
Adapalene—Seborrhoeic dermatitis—Clindamycin—malaria	0.0137	0.0189	CcSEcCtD
Adapalene—Optic neuritis—Quinidine barbiturate—malaria	0.0135	0.0186	CcSEcCtD
Adapalene—RXRA—liver—malaria	0.013	0.0607	CbGeAlD
Adapalene—RARG—digestive system—malaria	0.0128	0.0597	CbGeAlD
Adapalene—RARG—blood—malaria	0.0122	0.0569	CbGeAlD
Adapalene—Skin exfoliation—Sulfadiazine—malaria	0.012	0.0165	CcSEcCtD
Adapalene—Rash pustular—Clindamycin—malaria	0.0117	0.0162	CcSEcCtD
Adapalene—RARB—liver—malaria	0.0117	0.0545	CbGeAlD
Adapalene—Stinging—Clindamycin—malaria	0.0115	0.0159	CcSEcCtD
Adapalene—RARA—blood—malaria	0.0114	0.0535	CbGeAlD
Adapalene—RARA—bone marrow—malaria	0.0111	0.0518	CbGeAlD
Adapalene—RXRB—liver—malaria	0.0107	0.0501	CbGeAlD
Adapalene—RXRA—brain—malaria	0.0103	0.0482	CbGeAlD
Adapalene—Dermatitis exfoliative—Sulfadiazine—malaria	0.00966	0.0133	CcSEcCtD
Adapalene—RARB—brain—malaria	0.00925	0.0433	CbGeAlD
Adapalene—Dermatitis contact—Clindamycin—malaria	0.00924	0.0128	CcSEcCtD
Adapalene—Skin exfoliation—Dapsone—malaria	0.00923	0.0127	CcSEcCtD
Adapalene—Dermatitis contact—Quinidine—malaria	0.00906	0.0125	CcSEcCtD
Adapalene—Dermatitis contact—Quinine—malaria	0.00906	0.0125	CcSEcCtD
Adapalene—RXRG—brain—malaria	0.00904	0.0423	CbGeAlD
Adapalene—RARA—liver—malaria	0.00894	0.0418	CbGeAlD
Adapalene—Skin exfoliation—Clindamycin—malaria	0.00892	0.0123	CcSEcCtD
Adapalene—RXRB—brain—malaria	0.0085	0.0398	CbGeAlD
Adapalene—Erythema—Proguanil—malaria	0.00827	0.0114	CcSEcCtD
Adapalene—Dermatitis contact—Quinidine barbiturate—malaria	0.00818	0.0113	CcSEcCtD
Adapalene—RARG—brain—malaria	0.00755	0.0353	CbGeAlD
Adapalene—Eczema—Quinine—malaria	0.00741	0.0102	CcSEcCtD
Adapalene—Eczema—Quinidine—malaria	0.00741	0.0102	CcSEcCtD
Adapalene—Dermatitis exfoliative—Clindamycin—malaria	0.00719	0.00993	CcSEcCtD
Adapalene—Dermatitis bullous—Clindamycin—malaria	0.0071	0.0098	CcSEcCtD
Adapalene—RARA—brain—malaria	0.0071	0.0332	CbGeAlD
Adapalene—Dermatitis exfoliative—Quinidine—malaria	0.00705	0.00974	CcSEcCtD
Adapalene—Dermatitis exfoliative—Quinine—malaria	0.00705	0.00974	CcSEcCtD
Adapalene—Dermatitis bullous—Quinine—malaria	0.00696	0.00961	CcSEcCtD
Adapalene—Dermatitis bullous—Quinidine—malaria	0.00696	0.00961	CcSEcCtD
Adapalene—Eczema—Quinidine barbiturate—malaria	0.00668	0.00923	CcSEcCtD
Adapalene—Hypersensitivity—Pyrimethamine—malaria	0.00638	0.00881	CcSEcCtD
Adapalene—Dermatitis exfoliative—Quinidine barbiturate—malaria	0.00637	0.00879	CcSEcCtD
Adapalene—Hepatitis—Sulfadiazine—malaria	0.0063	0.0087	CcSEcCtD
Adapalene—Dermatitis bullous—Quinidine barbiturate—malaria	0.00629	0.00868	CcSEcCtD
Adapalene—Dry skin—Clindamycin—malaria	0.00622	0.00859	CcSEcCtD
Adapalene—Photosensitivity reaction—Dapsone—malaria	0.00553	0.00764	CcSEcCtD
Adapalene—Photosensitivity reaction—Clindamycin—malaria	0.00535	0.00739	CcSEcCtD
Adapalene—Photosensitivity reaction—Quinine—malaria	0.00525	0.00725	CcSEcCtD
Adapalene—Photosensitivity reaction—Quinidine—malaria	0.00525	0.00725	CcSEcCtD
Adapalene—Convulsion—Sulfadiazine—malaria	0.00475	0.00656	CcSEcCtD
Adapalene—Photosensitivity reaction—Quinidine barbiturate—malaria	0.00474	0.00654	CcSEcCtD
Adapalene—Hepatitis—Quinine—malaria	0.00461	0.00636	CcSEcCtD
Adapalene—Hepatitis—Quinidine—malaria	0.00461	0.00636	CcSEcCtD
Adapalene—Conjunctivitis—Pentoxifylline—malaria	0.00449	0.0062	CcSEcCtD
Adapalene—Rash—Proguanil—malaria	0.00425	0.00587	CcSEcCtD
Adapalene—Dermatitis—Proguanil—malaria	0.00425	0.00587	CcSEcCtD
Adapalene—Erythema—Dapsone—malaria	0.00422	0.00583	CcSEcCtD
Adapalene—Hepatitis—Quinidine barbiturate—malaria	0.00416	0.00574	CcSEcCtD
Adapalene—Hepatitis—Pentoxifylline—malaria	0.00415	0.00573	CcSEcCtD
Adapalene—RARG—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00414	0.0671	CbGpPWpGaD
Adapalene—Erythema—Clindamycin—malaria	0.00409	0.00564	CcSEcCtD
Adapalene—Erythema—Quinidine—malaria	0.00401	0.00553	CcSEcCtD
Adapalene—Erythema—Quinine—malaria	0.00401	0.00553	CcSEcCtD
Adapalene—RXRG—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00379	0.0614	CbGpPWpGaD
Adapalene—RARB—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00371	0.0602	CbGpPWpGaD
Adapalene—Angioedema—Quinine—malaria	0.00366	0.00506	CcSEcCtD
Adapalene—Angioedema—Quinidine—malaria	0.00366	0.00506	CcSEcCtD
Adapalene—Erythema—Quinidine barbiturate—malaria	0.00362	0.00499	CcSEcCtD
Adapalene—Erythema—Pentoxifylline—malaria	0.00361	0.00498	CcSEcCtD
Adapalene—RARA—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00356	0.0577	CbGpPWpGaD
Adapalene—RXRB—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00356	0.0577	CbGpPWpGaD
Adapalene—Urticaria—Sulfadiazine—malaria	0.00356	0.00491	CcSEcCtD
Adapalene—Convulsion—Quinidine—malaria	0.00347	0.00479	CcSEcCtD
Adapalene—Convulsion—Quinine—malaria	0.00347	0.00479	CcSEcCtD
Adapalene—Angioedema—Quinidine barbiturate—malaria	0.00331	0.00456	CcSEcCtD
Adapalene—Angioedema—Pentoxifylline—malaria	0.0033	0.00455	CcSEcCtD
Adapalene—Hypersensitivity—Sulfadiazine—malaria	0.0033	0.00455	CcSEcCtD
Adapalene—Pruritus—Sulfadiazine—malaria	0.00317	0.00437	CcSEcCtD
Adapalene—Convulsion—Quinidine barbiturate—malaria	0.00313	0.00433	CcSEcCtD
Adapalene—Convulsion—Pentoxifylline—malaria	0.00313	0.00432	CcSEcCtD
Adapalene—Pain—Clindamycin—malaria	0.00285	0.00394	CcSEcCtD
Adapalene—Rash—Sulfadiazine—malaria	0.00282	0.0039	CcSEcCtD
Adapalene—Dermatitis—Sulfadiazine—malaria	0.00282	0.00389	CcSEcCtD
Adapalene—Urticaria—Clindamycin—malaria	0.00265	0.00366	CcSEcCtD
Adapalene—Urticaria—Quinine—malaria	0.0026	0.00359	CcSEcCtD
Adapalene—Urticaria—Quinidine—malaria	0.0026	0.00359	CcSEcCtD
Adapalene—RARG—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.0026	0.0421	CbGpPWpGaD
Adapalene—Pain—Quinidine barbiturate—malaria	0.00252	0.00349	CcSEcCtD
Adapalene—Hypersensitivity—Clindamycin—malaria	0.00246	0.00339	CcSEcCtD
Adapalene—Hypersensitivity—Quinidine—malaria	0.00241	0.00333	CcSEcCtD
Adapalene—Hypersensitivity—Quinine—malaria	0.00241	0.00333	CcSEcCtD
Adapalene—RXRG—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00238	0.0385	CbGpPWpGaD
Adapalene—Pruritus—Clindamycin—malaria	0.00236	0.00326	CcSEcCtD
Adapalene—Urticaria—Quinidine barbiturate—malaria	0.00235	0.00324	CcSEcCtD
Adapalene—Urticaria—Pentoxifylline—malaria	0.00234	0.00323	CcSEcCtD
Adapalene—RARB—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00233	0.0378	CbGpPWpGaD
Adapalene—Pruritus—Quinine—malaria	0.00231	0.0032	CcSEcCtD
Adapalene—Pruritus—Quinidine—malaria	0.00231	0.0032	CcSEcCtD
Adapalene—RARA—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00223	0.0362	CbGpPWpGaD
Adapalene—RXRB—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00223	0.0362	CbGpPWpGaD
Adapalene—Hypersensitivity—Quinidine barbiturate—malaria	0.00218	0.003	CcSEcCtD
Adapalene—Hypersensitivity—Pentoxifylline—malaria	0.00217	0.003	CcSEcCtD
Adapalene—Rash—Clindamycin—malaria	0.0021	0.0029	CcSEcCtD
Adapalene—Dermatitis—Clindamycin—malaria	0.0021	0.0029	CcSEcCtD
Adapalene—Pruritus—Quinidine barbiturate—malaria	0.00209	0.00288	CcSEcCtD
Adapalene—Pruritus—Pentoxifylline—malaria	0.00209	0.00288	CcSEcCtD
Adapalene—Rash—Quinine—malaria	0.00206	0.00285	CcSEcCtD
Adapalene—Rash—Quinidine—malaria	0.00206	0.00285	CcSEcCtD
Adapalene—Dermatitis—Quinidine—malaria	0.00206	0.00284	CcSEcCtD
Adapalene—Dermatitis—Quinine—malaria	0.00206	0.00284	CcSEcCtD
Adapalene—Rash—Quinidine barbiturate—malaria	0.00186	0.00257	CcSEcCtD
Adapalene—Dermatitis—Quinidine barbiturate—malaria	0.00186	0.00257	CcSEcCtD
Adapalene—Rash—Pentoxifylline—malaria	0.00186	0.00257	CcSEcCtD
Adapalene—Dermatitis—Pentoxifylline—malaria	0.00186	0.00256	CcSEcCtD
Adapalene—RXRA—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.00186	0.0301	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00159	0.0257	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00145	0.0235	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00142	0.0231	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00136	0.0221	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.00136	0.0221	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.00123	0.0199	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.00118	0.0191	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—DECR1—malaria	0.00117	0.019	CbGpPWpGaD
Adapalene—RXRA—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.00116	0.0189	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—G6PD—malaria	0.000997	0.0162	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—FAS—malaria	0.000943	0.0153	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—FAS—malaria	0.000886	0.0144	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—TNF—malaria	0.000812	0.0132	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—CD36—malaria	0.000731	0.0118	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—malaria	0.000711	0.0115	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.00068	0.011	CbGpPWpGaD
Adapalene—RXRA—Biological oxidations—HPGDS—malaria	0.000667	0.0108	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—IL6—malaria	0.000656	0.0106	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000652	0.0106	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000613	0.00994	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—CD36—malaria	0.000549	0.0089	CbGpPWpGaD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—malaria	0.000538	0.00871	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—SLC4A1—malaria	0.000473	0.00766	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000467	0.00757	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—FAS—malaria	0.000462	0.00749	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PKLR—malaria	0.000422	0.00684	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—TNF—malaria	0.0004	0.00649	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TNF—malaria	0.000376	0.0061	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—malaria	0.00037	0.006	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.00034	0.0055	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—IL6—malaria	0.000323	0.00523	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—IL6—malaria	0.000304	0.00492	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—malaria	0.000298	0.00483	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000289	0.00468	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000277	0.00448	CbGpPWpGaD
Adapalene—RXRA—Metabolism—DHODH—malaria	0.00026	0.00422	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000256	0.00415	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000235	0.00381	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SLC4A1—malaria	0.000221	0.00359	CbGpPWpGaD
Adapalene—RXRA—Metabolism—DECR1—malaria	0.000208	0.00337	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TNF—malaria	0.000196	0.00318	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HBB—malaria	0.000188	0.00305	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PKLR—malaria	0.000168	0.00272	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CD36—malaria	0.000165	0.00268	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—IL6—malaria	0.000158	0.00257	CbGpPWpGaD
Adapalene—RXRA—Metabolism—G6PD—malaria	0.00015	0.00242	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—CD36—malaria	0.000148	0.00239	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TNF—malaria	0.000144	0.00234	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KDR—malaria	0.000143	0.00231	CbGpPWpGaD
Adapalene—RXRA—Metabolism—HPGDS—malaria	0.000114	0.00185	CbGpPWpGaD
Adapalene—RXRA—Metabolism—DHFR—malaria	0.000106	0.00171	CbGpPWpGaD
Adapalene—RXRA—Metabolism—SCARB1—malaria	0.000105	0.0017	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TNF—malaria	6.74e-05	0.00109	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CD36—malaria	6.57e-05	0.00106	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—IL6—malaria	5.44e-05	0.000882	CbGpPWpGaD
